Aristotle Capital Boston LLC decreased its position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 648,772 shares of the company's stock after selling 80,546 shares during the quarter. Aristotle Capital Boston LLC owned 1.31% of Nu Skin Enterprises worth $4,470,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Freestone Grove Partners LP acquired a new stake in Nu Skin Enterprises during the 4th quarter worth $299,000. Quarry LP increased its position in shares of Nu Skin Enterprises by 68.7% during the fourth quarter. Quarry LP now owns 21,707 shares of the company's stock worth $150,000 after purchasing an additional 8,839 shares in the last quarter. Boothbay Fund Management LLC lifted its holdings in shares of Nu Skin Enterprises by 97.9% in the 4th quarter. Boothbay Fund Management LLC now owns 33,131 shares of the company's stock valued at $228,000 after purchasing an additional 16,389 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Nu Skin Enterprises by 5.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 53,711 shares of the company's stock valued at $371,000 after purchasing an additional 2,702 shares during the period. Finally, Susquehanna International Group LLP increased its position in Nu Skin Enterprises by 191.9% during the fourth quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock worth $4,838,000 after buying an additional 461,608 shares during the period. 82.84% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th.
Get Our Latest Research Report on NUS
Nu Skin Enterprises Stock Performance
Shares of NUS stock traded down $0.13 during midday trading on Tuesday, hitting $5.80. The company had a trading volume of 598,013 shares, compared to its average volume of 836,941. Nu Skin Enterprises, Inc. has a 52-week low of $5.32 and a 52-week high of $14.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The company's 50 day simple moving average is $6.86 and its 200 day simple moving average is $6.95. The stock has a market cap of $288.14 million, a price-to-earnings ratio of -1.96 and a beta of 0.92.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. The company had revenue of $445.55 million during the quarter, compared to analysts' expectations of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were issued a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a dividend yield of 4.14%. Nu Skin Enterprises's dividend payout ratio is currently -8.14%.
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.